AstraZeneca is developing the vaccine with Oxford and says it could manufacture a billion doses by the end of 2021. The effort began human trials in April and expects results in two to six months.
U.S. gives $1 billion boost to Oxford coronavirus vaccine effort
More Stories
NOTIFIED: Dec. 12, 2020
Golden Retriever Puppy Is Totally Jealous of Toy Dog
Whoopi Goldberg to star in ‘Sister Act 3’